- Home
- TPET vs CVKD Comparison
TPET vs CVKD Comparison
Compare TPET & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPET
- CVKD
- Stock Information
- Founded
- TPET 2021
- CVKD 2022
- Country
- TPET United States
- CVKD United States
- Employees
- TPET N/A
- CVKD N/A
- Industry
- TPET Oil & Gas Production
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- TPET Energy
- CVKD Health Care
- Exchange
- TPET Nasdaq
- CVKD Nasdaq
- Market Cap
- TPET 8.6M
- CVKD 17.1M
- IPO Year
- TPET 2023
- CVKD 2023
- Fundamental
- Price
- TPET $0.15
- CVKD $16.30
- Analyst Decision
- TPET
- CVKD Strong Buy
- Analyst Count
- TPET 0
- CVKD 2
- Target Price
- TPET N/A
- CVKD $52.50
- AVG Volume (30 Days)
- TPET 5.7M
- CVKD 50.4K
- Earning Date
- TPET 09-12-2024
- CVKD 11-08-2024
- Dividend Yield
- TPET N/A
- CVKD N/A
- EPS Growth
- TPET N/A
- CVKD N/A
- EPS
- TPET N/A
- CVKD N/A
- Revenue
- TPET $135,975.00
- CVKD N/A
- Revenue This Year
- TPET N/A
- CVKD N/A
- Revenue Next Year
- TPET N/A
- CVKD N/A
- P/E Ratio
- TPET N/A
- CVKD N/A
- Revenue Growth
- TPET N/A
- CVKD N/A
- 52 Week Low
- TPET $0.08
- CVKD $5.40
- 52 Week High
- TPET $0.74
- CVKD $32.55
- Technical
- Relative Strength Index (RSI)
- TPET 38.64
- CVKD 70.84
- Support Level
- TPET $0.14
- CVKD $11.19
- Resistance Level
- TPET $0.16
- CVKD $15.93
- Average True Range (ATR)
- TPET 0.02
- CVKD 1.30
- MACD
- TPET 0.00
- CVKD 0.22
- Stochastic Oscillator
- TPET 12.35
- CVKD 97.25
About TPET Trio Petroleum Corp.
Trio Petroleum Corp is a California-focused oil and gas exploration and development company. It acquires, fund, and operate oil exploration and production from assets in California.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.